Syngenta Crop Protection AG v. UPL Ltd.
Panel: Taranto, Hughes, Cunningham
The Federal Circuit affirmed the PTAB's final written decision holding all claims of UPL Ltd.'s U.S. Patent No. 11,445,727 unpatentable, and also affirmed the Board's denial of Syngenta Crop Protection AG's request for leave to file a sanctions motion. The patent claims fungicidal combinations consisting of benzovindiflupyr (an SDHI fungicide), mancozeb (a dithiocarbamate fungicide), and at least one additional fungicide from specified classes. The Board found certain claims anticipated by prior art references Godoy and Tobler, and found other claims obvious over De Oliveira in view of Wiglesworth, Tobler, and Godoy.
The court's analysis centered on two principal issues: whether Syngenta's petition satisfied pleading requirements under 37 C.F.R. § 42.204(b)(4), and whether the Board correctly construed "combination" and "composition" to permit sequential application of component fungicides. The court held that where a patent owner first proposes claim construction in its response, the petitioner may elaborate in reply on how originally-identified prior art passages teach the disputed limitations without violating the bar on changing theories. On claim construction, the court found the specification's explicit statement that compositions "may be applied simultaneously as a tank mix or a formulation or may be applied sequentially" compelled treating "combination" and "composition" as interchangeable terms permitting sequential application, rejecting UPL's attempt to distinguish them.